Senologia

What Senologia does

Senologia is a micro-organization of approximately 6 employees operating under the website mammella.org. The company name "Senologia" (Italian for the medical specialty of breast study) and the domain "mammella" (Italian for breast) strongly suggest a focus on breast health, likely a clinical practice, specialist service, or association serving patients or members in the breast-care vertical. However, no substantive content was retrievable from the corporate website — the source page rendered only a verification/loader screen with no product, service, or organizational details.

No products, services, technology stack, pricing model, customer segments, management team, partnerships, certifications, funding history, or revenue figures were disclosed in the aggregated source data. All product, technology, and revenue model fields in the underlying datasets are empty. The headcount of 6 indicates a boutique operation; whether this is a clinical micro-practice, a patient advocacy organization, or a specialist consultancy cannot be determined from the available evidence.

Because the source material is limited to a loading screen and an empty firmographic record, any business model attribution — fee-for-service clinical revenue, subscription/membership dues, grant funding, or payor reimbursement — is unsupported by the input. Analysts should treat the entity as effectively data-poor until the corporate website publishes substantive content or alternative primary sources become available.

Name

Senologia

Website

https://mammella.org

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Senologia is a 6-person organization operating at mammella.org, whose name (Italian for "breast medicine") and domain suggest a focus on breast health. No products, services, customers, or revenue model are disclosed in available source data.

Ownership category

akta.pro rank

Product category

Breast Health Information

NAICS

Medical Laboratories (621511)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Data Management, Reporting & Regulatory Submissions for Central Labs (HLAGAEAL)

akta.pro secondary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

Keywords

• Breast health services
• Medical information portal
• Breast care resources
• Senology information
• Women's health content

GTM type

B2C

Offering type

Services

Core offering

No core offering can be described from the provided source data. The referenced source page (mammella.org) is a verification/loading screen that contains no substantive description of products, services, or business activities associated with Senologia.

Differentiator

Problem solved

Functional benefit

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Direct peers

• Therapixel: Therapixel developed MammoScreen, an AI software for mammography triage and decision support that is CE-marked and clinically deployed. It is a direct peer in applying digital tools to breast imaging workflow and reporting.
• Delphinus Medical Technologies: Delphinus commercializes SoftVue, a whole breast ultrasound system used adjunctively in breast cancer screening. It is a direct peer in advanced breast-imaging technology aimed at improving early detection.
• iCAD: iCAD offers ProFound AI for breast cancer detection and risk assessment, competing head-to-head with Therapixel and Volpara. It is a direct peer in AI-enabled breast diagnostics serving the same radiology and screening clinics.
• Volpara Health Technologies: Volpara provides AI-driven breast density, risk assessment, and reporting software used by breast imaging clinics worldwide. It is the closest direct peer to a breast-health-focused software/service play, addressing the same provider customers Senologia would need to serve.

Emerging players

• Metabolomic Technologies: Metabolomic Technologies developed the PolarisD urinary metabolomic test for breast cancer recurrence risk. It is an emerging peer operating at the intersection of breast diagnostics and patient-facing health information.
• Densitas: Densitas develops AI for breast density assessment and mammography quality, with regulatory clearances in multiple jurisdictions. It is an emerging peer with overlapping breast-imaging AI capabilities, relevant to any digital breast-health service.
• Real Imaging: Real Imaging develops 3D functional blood-flow-based breast cancer risk assessment technology. It is an emerging peer addressing the same breast-cancer screening and risk-stratification use cases that a breast-health service would route patients toward.

Broad incumbents

• GE HealthCare: GE HealthCare is a leading manufacturer of mammography systems and broader imaging infrastructure. It is a broad incumbent whose installed base and screening programs overlap with the breast-health service ecosystem Senologia would target.
• Siemens Healthineers: Siemens Healthineers produces mammography hardware and AI-enabled screening tools within a broader imaging portfolio. It is a broad incumbent operating in the same breast-screening delivery environment.
• Hologic: Hologic is the dominant manufacturer of mammography systems and the vendor behind the Genius AI detection platform used in breast cancer screening. It is the most comparable broad incumbent operating in Senologia's likely breast-health service and screening space.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks5 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/senologia

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Senologia